List of Tables
Table 1. Oncology Treatment Drug Market Trends
Table 2. Oncology Treatment Drug Market Drivers & Opportunity
Table 3. Oncology Treatment Drug Market Challenges
Table 4. Oncology Treatment Drug Market Restraints
Table 5. Global Oncology Treatment Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Oncology Treatment Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Oncology Treatment Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Oncology Treatment Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Oncology Treatment Drug
Table 10. Global Oncology Treatment Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Treatment Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Oncology Treatment Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Oncology Treatment Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Oncology Treatment Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Oncology Treatment Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Oncology Treatment Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Oncology Treatment Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Oncology Treatment Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Oncology Treatment Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Oncology Treatment Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Oncology Treatment Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Oncology Treatment Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Oncology Treatment Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Oncology Treatment Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Oncology Treatment Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Oncology Treatment Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Oncology Treatment Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Oncology Treatment Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Oncology Treatment Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. Roche Basic Information List
Table 32. Roche Description and Business Overview
Table 33. Roche Oncology Treatment Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Oncology Treatment Drug Business of Roche (2019-2024)
Table 35. Roche Recent Developments
Table 36. Celgene Basic Information List
Table 37. Celgene Description and Business Overview
Table 38. Celgene Oncology Treatment Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Oncology Treatment Drug Business of Celgene (2019-2024)
Table 40. Celgene Recent Developments
Table 41. Novartis Basic Information List
Table 42. Novartis Description and Business Overview
Table 43. Novartis Oncology Treatment Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Oncology Treatment Drug Business of Novartis (2019-2024)
Table 45. Novartis Recent Developments
Table 46. Bristol-Myers Squibb Basic Information List
Table 47. Bristol-Myers Squibb Description and Business Overview
Table 48. Bristol-Myers Squibb Oncology Treatment Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Oncology Treatment Drug Business of Bristol-Myers Squibb (2019-2024)
Table 50. Bristol-Myers Squibb Recent Developments
Table 51. Johnson & Johnson Basic Information List
Table 52. Johnson & Johnson Description and Business Overview
Table 53. Johnson & Johnson Oncology Treatment Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Oncology Treatment Drug Business of Johnson & Johnson (2019-2024)
Table 55. Johnson & Johnson Recent Developments
Table 56. Merck & Co. Basic Information List
Table 57. Merck & Co. Description and Business Overview
Table 58. Merck & Co. Oncology Treatment Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Oncology Treatment Drug Business of Merck & Co. (2019-2024)
Table 60. Merck & Co. Recent Developments
Table 61. AstraZeneca Basic Information List
Table 62. AstraZeneca Description and Business Overview
Table 63. AstraZeneca Oncology Treatment Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Oncology Treatment Drug Business of AstraZeneca (2019-2024)
Table 65. AstraZeneca Recent Developments
Table 66. Pfizer Basic Information List
Table 67. Pfizer Description and Business Overview
Table 68. Pfizer Oncology Treatment Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Oncology Treatment Drug Business of Pfizer (2019-2024)
Table 70. Pfizer Recent Developments
Table 71. Amgen Basic Information List
Table 72. Amgen Description and Business Overview
Table 73. Amgen Oncology Treatment Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Oncology Treatment Drug Business of Amgen (2019-2024)
Table 75. Amgen Recent Developments
Table 76. Eli Lilly Basic Information List
Table 77. Eli Lilly Description and Business Overview
Table 78. Eli Lilly Oncology Treatment Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Oncology Treatment Drug Business of Eli Lilly (2019-2024)
Table 80. Eli Lilly Recent Developments
Table 81. AbbVie Basic Information List
Table 82. AbbVie Description and Business Overview
Table 83. AbbVie Oncology Treatment Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Oncology Treatment Drug Business of AbbVie (2019-2024)
Table 85. AbbVie Recent Developments
Table 86. Takeda Basic Information List
Table 87. Takeda Description and Business Overview
Table 88. Takeda Oncology Treatment Drug Products, Services and Solutions
Table 89. Revenue (US$ Million) in Oncology Treatment Drug Business of Takeda (2019-2024)
Table 90. Takeda Recent Developments
Table 91. Astellas Basic Information List
Table 92. Astellas Description and Business Overview
Table 93. Astellas Oncology Treatment Drug Products, Services and Solutions
Table 94. Revenue (US$ Million) in Oncology Treatment Drug Business of Astellas (2019-2024)
Table 95. Astellas Recent Developments
Table 96. Ipsen Basic Information List
Table 97. Ipsen Description and Business Overview
Table 98. Ipsen Oncology Treatment Drug Products, Services and Solutions
Table 99. Revenue (US$ Million) in Oncology Treatment Drug Business of Ipsen (2019-2024)
Table 100. Ipsen Recent Developments
Table 101. Sanofi Basic Information List
Table 102. Sanofi Description and Business Overview
Table 103. Sanofi Oncology Treatment Drug Products, Services and Solutions
Table 104. Revenue (US$ Million) in Oncology Treatment Drug Business of Sanofi (2019-2024)
Table 105. Sanofi Recent Developments
Table 106. Bayer Basic Information List
Table 107. Bayer Description and Business Overview
Table 108. Bayer Oncology Treatment Drug Products, Services and Solutions
Table 109. Revenue (US$ Million) in Oncology Treatment Drug Business of Bayer (2019-2024)
Table 110. Bayer Recent Developments
Table 111. Biogen Idec Basic Information List
Table 112. Biogen Idec Description and Business Overview
Table 113. Biogen Idec Oncology Treatment Drug Products, Services and Solutions
Table 114. Revenue (US$ Million) in Oncology Treatment Drug Business of Biogen Idec (2019-2024)
Table 115. Biogen Idec Recent Developments
Table 116. Teva Basic Information List
Table 117. Teva Description and Business Overview
Table 118. Teva Oncology Treatment Drug Products, Services and Solutions
Table 119. Revenue (US$ Million) in Oncology Treatment Drug Business of Teva (2019-2024)
Table 120. Teva Recent Developments
Table 121. Otsuka Basic Information List
Table 122. Otsuka Description and Business Overview
Table 123. Otsuka Oncology Treatment Drug Products, Services and Solutions
Table 124. Revenue (US$ Million) in Oncology Treatment Drug Business of Otsuka (2019-2024)
Table 125. Otsuka Recent Developments
Table 126. Eisai Basic Information List
Table 127. Eisai Description and Business Overview
Table 128. Eisai Oncology Treatment Drug Products, Services and Solutions
Table 129. Revenue (US$ Million) in Oncology Treatment Drug Business of Eisai (2019-2024)
Table 130. Eisai Recent Developments
Table 131. Merck KGaA Basic Information List
Table 132. Merck KGaA Description and Business Overview
Table 133. Merck KGaA Oncology Treatment Drug Products, Services and Solutions
Table 134. Revenue (US$ Million) in Oncology Treatment Drug Business of Merck KGaA (2019-2024)
Table 135. Merck KGaA Recent Developments
Table 136. Gilead Sciences Basic Information List
Table 137. Gilead Sciences Description and Business Overview
Table 138. Gilead Sciences Oncology Treatment Drug Products, Services and Solutions
Table 139. Revenue (US$ Million) in Oncology Treatment Drug Business of Gilead Sciences (2019-2024)
Table 140. Gilead Sciences Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Oncology Treatment Drug Downstream Customers
Table 144. Oncology Treatment Drug Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 148. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Oncology Treatment Drug Product Picture
Figure 2. Global Oncology Treatment Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Oncology Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Oncology Treatment Drug Report Years Considered
Figure 5. Global Oncology Treatment Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology Treatment Drug Revenue in 2023
Figure 7. Oncology Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Chemotherapy Picture
Figure 9. Targeted Therapy Picture
Figure 10. Immunotherapy (Biologic Therapy) Picture
Figure 11. Hormonal Therapy Picture
Figure 12. Others Picture
Figure 13. Global Oncology Treatment Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Oncology Treatment Drug Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Blood Cancer
Figure 16. Product Picture of Breast Cancer
Figure 17. Product Picture of Gastrointestinal Cancer
Figure 18. Product Picture of Prostate Cancer
Figure 19. Product Picture of Respiratory/Lung Cancer
Figure 20. Product Picture of Others
Figure 21. Global Oncology Treatment Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Oncology Treatment Drug Sales Value Market Share by Application, 2023 & 2030
Figure 23. North America Oncology Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 25. Europe Oncology Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 27. Asia Pacific Oncology Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia Pacific Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 29. South America Oncology Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 30. South America Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Oncology Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 33. Key Countries/Regions Oncology Treatment Drug Sales Value (%), (2019-2030)
Figure 34. United States Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 35. United States Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 36. United States Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 37. Europe Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 38. Europe Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 39. Europe Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 40. China Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 41. China Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 42. China Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 43. Japan Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 44. Japan Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 45. Japan Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 46. South Korea Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 47. South Korea Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 48. South Korea Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 49. Southeast Asia Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 51. Southeast Asia Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 52. India Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 53. India Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 54. India Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 55. Oncology Treatment Drug Industrial Chain
Figure 56. Oncology Treatment Drug Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
